Key Events This Week
25 May: Stock opens steady at Rs.9.25
26 May: Plunges to lower circuit at Rs.8.80 amid heavy selling pressure
27 May: Continues decline, closing at Rs.8.70
29 May: Surges to upper circuit, closing at Rs.9.00
Jul 17, 03:30 PM
BSE+NSE Vol: 24000

JFL Life Sciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 29 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 10 July 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and technical outlook.
Read full news article
At Rs 11.45, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. JFL Life Sciences Ltd locked at its upper circuit of 4.57% on 7 Jul 2026, with buyers queuing and no sellers willing to part with shares.
Read full news article
At Rs 10.95, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. JFL Life Sciences Ltd locked at its upper circuit of 4.31% on 7 Jul 2026, with buyers queuing and no sellers willing to part with shares.
Read full news article
JFL Life Sciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 29 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 29 June 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Read full news article
JFL Life Sciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 29 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 17 June 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.
Read full news article
At Rs 9.90, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. JFL Life Sciences Ltd locked at its upper circuit of 4.76% on 2 Jun 2026, with buyers queuing and no sellers willing to part with shares.
Read full news article
At Rs 9.45, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. JFL Life Sciences Ltd locked at its upper circuit of 5.0% on 1 Jun 2026, with buyers queuing and no sellers willing to part with shares.
Read full news article
JFL Life Sciences Ltd., a micro-cap pharmaceutical manufacturer with a market capitalisation of ₹57.00 crores, reported a dramatic 134.91% quarter-on-quarter revenue surge to ₹63.05 crores in Q4 FY26, marking the company's strongest quarterly sales performance on record. However, this topline expansion came at a significant cost to profitability, with operating margins contracting sharply to 5.57% from 12.48% in the previous quarter, raising critical questions about the sustainability and quality of this growth trajectory.
Read full news article